Artwork

Content provided by EY. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EY or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

How shorter clinical trial processes prolong the lives of patients

29:14
 
Share
 

Manage episode 305124830 series 2402091
Content provided by EY. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EY or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss the use of technology in medicine and what makes an increase in the volume of clinical trials, including cgt clinical trials, and an acceleration of the clinical trial process significant.
  continue reading

10 episodes

Artwork
iconShare
 
Manage episode 305124830 series 2402091
Content provided by EY. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by EY or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy. In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss the use of technology in medicine and what makes an increase in the volume of clinical trials, including cgt clinical trials, and an acceleration of the clinical trial process significant.
  continue reading

10 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide